Video
In addition to overall concerns about COVID-19 vaccines patients may have stronger fears about the second vaccine dose since it is often accompanied with more adverse effects.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria